Abstract. Development of a Cyclotron manufacturing facility begins with a business plan. Geographics, the size and activity of the medical community, the growth potential of the modality being served, and other business connections are all considered. This business used the customer base established by NuTech, Inc., an independent centralized nuclear pharmacy founded by Danny Allen. With two pharmacies in operation in Tyler and College Station and a customer base of 47 hospitals and clinics the existing delivery system and pharmacist staff is used for the cyclotron facility. We then added cyclotron products to contracts with these customers to guarantee a supply. We partnered with a company in the process of developing PET imaging centers. We then built an independent imaging center attached to the cyclotron facility to allow for the use of short-lived isotopes.
INTRODUCTION
The terms Time, Distance, Shielding take on a whole new meaning in the development of a complicated, newly evolving business. Time to develop is in the control of many other people. Distance is all the destinations traveled during the development phase, and Shielding is the wall you have to build around yourself to get the process underway. The purpose of this presentation is to address the process and purpose of developing a medical cyclotron facility.
BUSINESS PLAN
Based on the evolution of PET imaging into a first choice diagnostic tool for medical imaging, and the acceptance of insurance and Medicare to pay for the use of this modality, we began to explore the possibilities of incorporating this modality into our existing business.
We currently operate two centralized nuclear pharmacies in Tyler and College Station, Texas which service 47 hospitals and clinics. The nuclear medicine departments we service are beginning to use or are developing plans to use PET imaging. We were approached by a company which was developing PET imaging centers in Louisiana and wanted to expand into Texas. We partnered with them to open imaging centers in Texas to be supplied by a cyclotron center we would develop. With our existing nuclear pharmacy delivery system we could also supply any of the hospitals and clinics we are currently servicing. We would also attach the cyclotron facility to the imaging center we built in Tyler to allow for imaging procedures to be performed that could not be done at remote centers.
FLEXIBILITY
We approached the business with flexibility in mind. We are purchasing a cyclotron with deuteron capabilities, dual beam, and six target holders. Our building design includes a vault with a poly shield. This allows us to have more flexibility for future targetry and possible machine upgrades without shielding manipulations. The design includes a future vault and piping included in the design for this cyclotron. We are building a research lab in the building for the possibility of attracting research grants either using the initial cyclotron or the future one.
The building is designed to meet FDA manufacturing specifications.
The six nuclear pharmacists working in the nuclear pharmacy will be cross trained and leased to the cyclotron nuclear pharmacy facility. The delivery system at the existing nuclear pharmacy will be used by the cyclotron facility to service the same customer base.
A nuclear engineer has been hired to help in the development, maintenance, operations, and research activities. Although the business plan is based on FDG production we plan to explore the possibilities of producing existing isotopes and developing new radiopharmaceuticals.
Having an extremely flexible and capable facility, staff, and business plan will allow us to pursue opportunities other facilities are not capable of doing. We will also be secure with meeting future regulatory issues without affecting production.
FACILITY DESIGN
The facility design takes into consideration state regulations, climate considerations, as well as necessary redundancy.
The vault was designed to meet and exceed current shielding needs. A poly shield is put in place to alleviate any concerns the regulatory body might have with concrete activation in the vault. A bond was avoided using this method. Humidity is a concern in our location. This issue was addressed by designing an air conditioning system using chillers and a boiler. Two 30 ton chillers will be used. This allows for redundancy for the cyclotron chilling system as well as cooling the facility. A boiler is used to reheat the chilled air to room temperature thus allowing for humidity control. Digital controls are used.
An exhaust system with in line charcoal filters is incorporated in the design to trap in volatile release of radioactive material as well as to create appropriate negative air flow in the areas where radioactive material is used. All air in the restricted area flows towards the vault.
Restricted and unrestricted areas have separate air handling systems. A generator system is employed in case of power failure. Although this will not run the cyclotron it will run the chemistry boxes and computers so that a production run underway would not be interrupted.
Radioactive material is transferred automatically via underground lines from the cyclotron to the chemistry boxes and then to the dose drawing station in the clean room where a customized hot cell with robotics arms is used for dose preparation. The hot cell pulls hepafiltered laminar flow air and has a negative pressure exhaust into the buildings charcoal filter exhaust system. Work flow patterns were also important in the design of the building due to radiation safety considerations. 
MARKETING
While working on design and construction we have pursued future business via contracts with existing customers and potential customers, as well as bringing speakers to the area in an attempt to educate referring physicians on this fledgling modality. We also continue to work with our partners on opening new imaging centers as well begin to service some customers in advance by using out existing delivery system to delivery product from existing cyclotrons to our customers.
CONCLUSION
As construction continues on our facility we will continue to pursue new areas for revenue generation such as research, manufacturing of needed isotopes, and expansion of imaging usage of FDG as well as other isotopes.
